abstract |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt thereof, wherein Z 1 , Z 2 , R 1 and R 2 are as defined herein are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. |